Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
*Solanum virginianum* methanolic leaf extract is a botanical preparation derived from the leaves of the *Solanum virginianum* plant, commonly known as Yellow-fruit nightshade or Kantakari. Historically utilized in Ayurvedic medicine as a component of the "Dashamula" formulation for respiratory and inflammatory conditions, recent research has focused on its potential as an antineoplastic agent. Preclinical studies indicate that the extract induces apoptosis in breast cancer cells (specifically the MDA-MB-231 line) by modulating both intrinsic and extrinsic pathways. This is achieved through the upregulation of pro-apoptotic factors such as BAX and caspases (CASP3, CASP8, CASP9) and the downregulation of the anti-apoptotic protein BCL2. Additionally, the extract demonstrates anti-metastatic potential by inhibiting the expression of matrix metalloproteinases MMP2 and MMP9. It has also shown synergistic effects when combined with melatonin, enhancing its anti-tumorigenic and anti-migratory properties.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on solanum virginianum methanolic leaf extract.